Malondialdehyde (MDA) is a major lipid peroxidation product that is mutagenic and tumorigenic. MDA-modified DNA adducts have been detected in animal and human tissues and may be a marker of human cancer risk. An immunohistochemical method, using a previously generated monoclonal antibody specific for MDA-DNA adducts, has been developed for the detection and quantification of DNA damage in human oral mucosa cells. The method was used initially on woodchuck liver cells treated with and without MDA, and then applied to the detection of adducts in oral mucosa cells of smokers and nonsmokers. Levels of DNA damage were elevated in 25 smokers (mean relative staining intensity 97 ⍨ 41) compared with 25 age-, race-and sex-matched non-smokers (74 ⍨ 17, P < 0.02). These results demonstrate that MDA-DNA adducts can be measured in single cells of human samples by an immunohistochemical method. This methodology provides a simple way to monitor MDA-DNA damage and should be useful for studies investigating the role of exogenous and endogenous agents in oxidative stress and carcinogenesis.
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Malondialdehyde (MDA) is a naturally occurring endogenous product of lipid peroxidation and prostaglandin biosynthesis; it participates in a variety of chemical and biological reactions including covalent binding to protein, RNA and DNA (1) . The reaction of MDA with deoxyguanosine gives rise to cyclic adducts, formed by the reaction of the carbonyl carbons of MDA at the N 1 and N 2 position of guanine. The major DNA adduct of MDA is a pyrimidopurinone of deoxyguanosine (M1G) (2), although adenine adducts are also formed (3). MDA is mutagenic in bacterial and mammalian cells producing both frame shift and base pair mutations (4), and is carcinogenic in rats (2) .
The endogenous formation of MDA during intracellular oxidative stress and its reaction with biologically important macromolecules makes MDA-DNA adducts a suitable biomarker of endogenous DNA damage. Marnett et al. have developed sensitive and reliable analytical methods for the detection and quantification of adducts in human and animal samples, including gas chromatography/mass spectroscopy (GC/MS) (5-8) and 32 P-post-labeling (9) . More recently, a monoclonal antibody was developed against M1G coupled to Abbreviations: GC/MS, gas chromatography/mass spectroscopy; HPLC, highperformance liquid chromatography; MDA, malondialdehyde. a carrier protein and found to have low cross-reactivity with other related endogenous exocyclic adducts (1) . When used in an immunoslot blot assay, the detection level was 2.5 adducts/ 10 8 nucleotides, comparable with that of other methods, but requiring much lower amounts of DNA (10) . The immunoassay was validated by the comparison of data on four white blood cell DNA samples to adduct detection by high-performance lipid chromatography (HPLC)/post-labeling (10). After correction for the 50% recovery of the HPLC/post-labeling method, there was a good correlation between the two assays with slightly lower levels reported for the immunoassay. MDA-DNA adducts have been detected in human liver and pancreas by GC/MS (6,7) and in breast, lung and white blood cells by post-labeling (9) (10) (11) (12) . Using these methods, levels of MDAdG in various human tissues ranged from 2.2 adducts/10 9 to 1.1 adducts/10 6 nucleotides by the different methods (6, 7, (9) (10) (11) (12) .
Immunohistochemical methods have been used extensively to monitor DNA damage in humans with exposure to polycyclic aromatic hydrocarbons, aflatoxin B 1 , 4-aminobiphenyl, 8-methoxypsoralen and UV radiation (reviewed in ref. 13) . Oxidative DNA damage has also been measured in human tissues (14) . Here, we have used the monoclonal antibody against MDA-DNA to develop an immunoperoxidase method for detection of this damage. The method was initially tested using cells treated in culture with MDA, then applied to the detection of damage in oral mucosa cells of smokers and nonsmokers. This method should be useful for the sensitive detection of DNA damage in small numbers of cells and tissue sections.
To develop the quantitative immunoperoxidase method, woodchuck liver cells (WC3 cells, Dr C.Rogler, Albert Einstein Medical Center, Bronx, New York) were cultured in 8 chambered slides (Nunc, Naperville, IL) with 10% fetal calf serum RPMI 1640 with L-glutamine (Cellgro, Herndon, VA). When cells were 50-60% confluent, they were treated for 2.5 h at 37°C with 0, 10, 20 and 40 mM MDA which was prepared from malonaldehyde bis(diethyl acetal) by treatment with acid as described previously (10) . After treatment, cells were washed with 1ϫ phosphate-buffered saline (PBS) twice and fixed in -20°C methanol:acetic acid (3:1) for 10 min, then transferred to -20°C acetone for another 10 min. Slides were stored at -20°C until stained.
Human subjects. Volunteers were recruited after Institutional Review Board approval by advertisements around New York Presbyterian Hospital. After informed consent was obtained, oral mucosa cells were collected by rinsing the mounth with 1ϫ PBS. Cells were smeared on pre-coated slides, air-dried and fixed as for the woodchuck liver cells. Samples were obtained from 25 smokers of at least 1 pack/day (range 20-30 cigarettes/day) and 25 race-, sex-and age-matched (within 5 years) non-smokers and were coded for analysis. A questionnaire was administered collecting information on smoking history.
Immunoperoxidase staining. Slides were washed with 1ϫ PBS, treated with RNase (100 µl/ml; Sigma Chemical, St Louis, MO) at 37°C for 1 h, washed with 1ϫ PBS, treated with proteinase K (10 µg/ml; Sigma) at room temperature for 10 min and washed. To denature the DNA, slides were incubated with 4 N HCl for 10 min and then with 50 mM Tris base for 5 min, both at room temperature. After washing with 1ϫ PBS, slides were incubated with 0.3% H 2 O 2 in methanol at room temperature for 30 min to quench endogenous peroxidase activity. Non-specific binding was blocked with 1.5% normal horse serum and then slides were incubated overnight at 4°C with anti-MDA monoclonal antiserum number D10A1 (kindly supplied by Dr Lawrence Marnett, Vanderbilt University, 1:6000 dilution in 1.5% normal horse serum). Elite mouse ABC and DAB kits (Vector Laboratories, Burlingame, CA) were used for visualization of bound antibody as directed by the manufacturer. Slides were dehydrated and cleaned in serial ethyl alcohol and xylene and mounted with Permount (Fisher Scientific, Pittsburgh, PA). To demonstrate the specificity of staining, human oral cells from a smoker were pre-treated with DNase (500 µg/ml for 1 h at 37°C) before staining, stained with a non-specific antibody (9D8, 1:50 dilution of hybridoma supernatant) recognizing DNA damage produced by the photoactivated drug 8-methoxypsoralen (15) or with antibody pre-absorbed with MDA-DNA (4.5 µg/ml for 30 min at 37°C) before use. MDA-DNA used for preabsorption was prepared as described previously (16) . A Cell 
208
Analysis System 200 microscope (Becton Dickinson, Elmhurst, IL) was used to measure the relative intensity of nuclear staining in 50 randomly selected cells using the Cell Measurement Program software package. Data presented are the object average optical density multiplied by 1000. Statistic analysis. The difference in mean value of relative staining intensity between smokers and non-smokers was analyzed by paired t-test. Two sided P values were calculated and values Ͻ0.05 were considered significant. Data were also analyzed after being log transformed to normalize the distribution.
Specific nuclear staining was observed in WC3 cells treated with MDA but not in untreated cells with representative staining as illustrated in Figure 1A and B, respectively. Quantification of staining indicated a dose-related increase in staining with relative staining intensities of 29 Ϯ 5, 46 Ϯ 4, 109 Ϯ 22, 115 Ϯ 24 in cells treated with 0, 10, 20 and 40 mM MDA, respectively. The immunoperoxidase method was then applied to the detection of damage in oral mucosa cells from smokers and non-smokers. To standardize the assay for possible day-to-day variation, MDA-treated and untreated WC3 cells were stained with each batch of human samples. The coefficient of variation for the positive and negative controls was 12 and 10%, respectively (n ϭ 4). One-way analysis of variance indicated there was no significant difference in repeat staining of WC3 cells. Representative staining in a smoker (No. 44) and non-smoker (No. 34) are illustrated in Figure 1C and D, respectively. As additional controls for staining specificity, oral cells of a smoker not paired to a non-smoker were stained. Pre-absorption of the primary antibody with MDA-DNA before use decreased staining from 109 Ϯ 39 to 63 Ϯ 9 ( Figure 1E ). Pre-treatment with DNase decreased relative staining to 43 Ϯ 7 ( Figure 1F ) whereas staining with a nonspecific antibody recognizing DNA damage produced by 8-methoxypsoralen gave a value of 45 Ϯ 9 for the same subject (not shown).
Quantification of staining intensity for all subjects is 
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given in Table I . Higher levels of specific nuclear staining were observed in most smokers compared with their matched non-smokers. The distribution of staining in smokers and non-smokers is given in Figure 2 . Variation in staining was 2.5-fold in non-smokers (range from 47 Ϯ 15 to 117 Ϯ 46) and 4.5-fold in smokers (from 44 Ϯ 7 to 197 Ϯ 66). The mean level of relative staining intensity was elevated 1.3-fold in smokers (mean 97 Ϯ 41) compared with nonsmokers (mean 74 Ϯ 17, P ϭ 0.02). After log transformation the mean value in smokers was 4.49 Ϯ 0.42 and in nonsmokers 4.29 Ϯ 0.23 (P ϭ 0.04).
DNA damage in humans is the result of exposure to exogenous chemicals, including environmental pollutants or their metabolites as well as normal metabolic processes. Several studies have emphasized the importance of the identification, characterization and quantitative determination of electrophiles of endogenous origin (17) (18) (19) . It is now known that significant DNA damage occurs endogenously through interaction with reactive chemical species, which arise during normal metabolism or through endogenous processes such as oxidation, methylation, deamination, depurination (20) (21) (22) (23) and inflammation (18) . Thus, endogenous DNA damage may contribute to the aetiology of human genetic disease and cancer.
Lipid peroxidation generates a complex variety of products many of which are reactive electrophiles; MDA appears to be the most mutagenic and carcinogenic (3). In the current study, an immunoperoxidase method was developed to detect MDA-DNA adducts using a previously developed monoclonal antibody and it was applied to the detection of endogenous damage in human oral mucosa cells. A relatively large interindividual variation in adduct levels was observed, 2.5-fold in non-smokers and 4.5-fold in smokers (Table I ). Similar or even higher variation was reported in previous human studies for other types of DNA damage (6, 9) . This is most likely a result of genetically determined interindividual differences in the rate and extent of intracellular oxidation processes and/or differences in DNA repair rates (24) .
Cigarette smoke, in both the gaseous phase and condensed particles, contains alkenes, nitrosamines, aromatic and heterocyclic hydrocarbons and amines. In addition, it is an excellent source of reactive oxygen species (ROS), such as hydroxyradicals, superoxides and peroxides that are capable of initiating or promoting oxidative damage (25) (26) (27) . Reaction of the ROS with cellular DNA results in oxidative damage, including a number of oxidized bases, single-strand breaks and/or alkali-labile lesion (28) . These types of DNA damage are considered to be crucial in cancer development, thus providing an additional possible mechanism for the apparent association between smoking and mouth, lung, pharynx, esophagus, bladder and cervical cancers (28) . A 1.3-fold higher level of specific nuclear staining for MDA-DNA in smokers compared with that in non-smokers was observed. This is somewhat lower than the 1.7-2-fold differences observed when staining oral cells of smokers and nonsmokers for the bulky PAH-and 4-ABP-DNA adducts or 8-hydroxy or oxo-deoxyguanosine, a useful marker of DNA damage produced by oxygen radicals (14) . Diet, alcohol consumption, carcinogen exposure, certain diseases and genetic factors have been associated with the extent of lipid peroxidation (12) . These factors, which were unmeasured in the present study, may account for the smaller differences observed in MDA-DNA adducts compared with those of the bulky carcinogens.
Like other analytic methods, the immunohistochemical assay has advantages and disadvantages. The major advantages are its ability to detect DNA damage in specific cell types within a tissue, and its applicability to small amounts of sample, even single cells. If used on blood cells, Ͻ1 ml of blood is required and DNA isolation is not necessary. Staining can be evaluated in a qualitative or semiquantitative manner. Qualitative assessment uses a subjective estimation of staining intensity and/or number of positively stained cells with an arbitrary scale whereas semiquantitative methods measure level of staining in the cells. The major disadvantage of the method is that absolute quantification, in terms of adducts per nucleotide, is not possible and data are expressed as relative staining intensity. This is not a problem for most studies in which subjects with different exposures or disease states are compared. In addition, the immunohistochemistry method is generally not as sensitive as competitive ELISA, slot blot, GC/MS or post-labeling. Although the MDA-DNA antibody appears to be highly specific for this adduct (1), antibody cross-reactivity with other adducts with a similar structure may potentially cause problems in quantification. In summary, this study demonstrated that the immunoperoxidase method is sufficiently sensitive to be useful in the detection of MDA-DNA adducts in human samples. MDA-DNA adducts may serve a biomarker of DNA damage by lipid peroxidation induced endogenously or exogenously.
